Stockreport

New Strong Sell Stocks for March 28th [Yahoo! Finance]

Artelo Biosciences, Inc.  (ARTL) 
US:NASDAQ Investor Relations: artelobio.com/investors
PDF The Zacks Consensus Estimate for its current year earnings has been revised 13.1% downward over the last 60 days. Artelo Biosciences, Inc. ARTL is a biopharmaceutical [Read more]